Investors looking for defensive exposure to essential goods often turn to consumer staples ETFs, yet the available options differ in meaningful ways. This comparison examines the Global X PureCap MSCI Consumer Staples ETF (GXPS), a focused and uncapped low-cost vehicle, against the iShares U.S. Consumer Staples ETF (IYK), a longer-standing fund with broader diversification and a healthcare component. Their distinct weighting schemes, holdings, fees, and liquidity profiles create different risk and return characteristics that matter when evaluating sector exposure in the current environment.
GXPS tracks the MSCI USA Consumer Staples Index, an uncapped, free-float market-capitalization-weighted benchmark. This design permits larger holdings to dominate, resulting in concentrated exposure across approximately 31 stocks where the top 10 account for about 80% of assets. Key positions include WMT at roughly 16%, COST near 14%, along with PG, KO, and PM. By industry the fund allocates about 44% to food, beverage and tobacco, 38% to consumer staples distribution and retail, and 18% to household and personal products. It carries a 0.15% expense ratio, uses representative sampling, and launched in July 2025 with AUM still in the tens of millions.
IYK follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, which imposes limits on individual and aggregate issuer weights. The fund holds around 54 stocks and shows a modest healthcare tilt, with roughly 56% in food, beverage and tobacco, 21% in household and personal products, 13% in health care equipment and services, and smaller allocations elsewhere. Top holdings feature PG and KO each near 13%, PM at about 12%, PEP, plus MCK and CVS. The expense ratio stands at 0.38%, the fund launched in June 2000, and it manages approximately $1.6 billion in AUM with strong liquidity.
The consumer staples sector continues to serve as a defensive area during uncertain economic periods, supported by steady demand for food, beverages, tobacco, and household essentials. Recent rotations into the sector reflect concerns over growth, inflation, and valuations in other areas. At the same time, companies face input-cost pressures, shifts toward value products, and regulatory issues in tobacco. GLP-1 drug trends and retailer dynamics also influence packaged foods and retail holdings, creating a mixed yet generally supportive setting for defensive allocations. I also checked this using Tickeron’s AI Screener to see how the two funds compare on momentum and volatility metrics.
Both ETFs reflect defensive characteristics, yet their approaches diverge. GXPS concentrates in mega-cap names such as WMT and COST, whose scale supports steadier earnings. IYK spreads exposure across more holdings and includes healthcare distribution, which can moderate pure staples momentum while reducing volatility. GXPS, being non-diversified and top-heavy, carries higher single-name and liquidity risk as a newer, smaller fund, while IYK’s capped structure and equity beta near 0.35 historically provide a smoother profile. The fee gap also stands out: GXPS at 0.15% is less than half of IYK’s 0.38%.
When evaluating funds like these, I find it helpful to run quick scans for relative positioning and technical signals. Tickeron’s AI Screener lets me filter ETFs by industry, volatility, and performance metrics in a single view, which streamlines the process of spotting how concentration versus diversification plays out in real time. It has become a regular part of my workflow for comparing sector vehicles without manual data pulls.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 32 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples